Masao Ogata

4.9k total citations
154 papers, 2.8k citations indexed

About

Masao Ogata is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, Masao Ogata has authored 154 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 50 papers in Epidemiology and 33 papers in Hematology. Recurrent topics in Masao Ogata's work include Cytomegalovirus and herpesvirus research (34 papers), Viral-associated cancers and disorders (26 papers) and Polyomavirus and related diseases (20 papers). Masao Ogata is often cited by papers focused on Cytomegalovirus and herpesvirus research (34 papers), Viral-associated cancers and disorders (26 papers) and Polyomavirus and related diseases (20 papers). Masao Ogata collaborates with scholars based in Japan, United States and Malaysia. Masao Ogata's co-authors include Tomohiro Mochizuki, S Hukuda, K Shichikawa, Shirô Shigeta, Eiichi Ohtsuka, Takahiro Fukuda, Takako Satou, Hiroshi Kikuchi, Jun‐ichi Kadota and Kazuhiro Kohno and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Diabetes.

In The Last Decade

Masao Ogata

142 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masao Ogata Japan 28 1.1k 833 615 574 505 154 2.8k
Minoru Nakamura Japan 36 1.5k 1.4× 427 0.5× 1.2k 2.0× 780 1.4× 184 0.4× 130 3.9k
Kenneth I. Welsh United Kingdom 37 881 0.8× 155 0.2× 1.5k 2.5× 507 0.9× 381 0.8× 68 4.2k
Erik Teske Netherlands 34 296 0.3× 351 0.4× 329 0.5× 392 0.7× 218 0.4× 160 3.7k
Shogo Tanaka Japan 30 675 0.6× 1.0k 1.2× 191 0.3× 1.5k 2.6× 126 0.2× 220 3.5k
S Romagnani Italy 27 427 0.4× 394 0.5× 2.8k 4.5× 341 0.6× 218 0.4× 46 4.4k
David R. Withers United Kingdom 40 626 0.6× 676 0.8× 3.6k 5.9× 1.4k 2.4× 159 0.3× 95 5.3k
Sankichi Horiuchi Japan 18 327 0.3× 877 1.1× 1.1k 1.7× 166 0.3× 167 0.3× 40 2.8k
Hiroshi Fujiwara Japan 22 369 0.3× 551 0.7× 602 1.0× 91 0.2× 67 0.1× 113 1.7k
M Ricci Italy 30 392 0.4× 290 0.3× 2.6k 4.2× 243 0.4× 288 0.6× 93 4.8k
Pejman Soroosh United States 32 380 0.4× 432 0.5× 2.6k 4.2× 800 1.4× 80 0.2× 50 3.8k

Countries citing papers authored by Masao Ogata

Since Specialization
Citations

This map shows the geographic impact of Masao Ogata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masao Ogata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masao Ogata more than expected).

Fields of papers citing papers by Masao Ogata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masao Ogata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masao Ogata. The network helps show where Masao Ogata may publish in the future.

Co-authorship network of co-authors of Masao Ogata

This figure shows the co-authorship network connecting the top 25 collaborators of Masao Ogata. A scholar is included among the top collaborators of Masao Ogata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masao Ogata. Masao Ogata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Ryota, Yosuke Suzuki, Takashi Inagaki, et al.. (2025). Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin‐I as an Endogenous Biomarker. Clinical Pharmacology & Therapeutics. 118(1). 128–137.
2.
Arai, Yasuyuki, Tadakazu Kondo, Shigeki Hirabayashi, et al.. (2025). HLA‐matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML. eJHaem. 6(1). e21088–e21088.
4.
Ogata, Masao, Kumi Oshima, Kuniko Takano, et al.. (2024). Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study. International Journal of Hematology. 119(4). 432–441. 3 indexed citations
5.
Onozawa, Masahiro, Shigeru Kusumoto, Yuho Najima, et al.. (2024). Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study. Transplantation and Cellular Therapy. 30(3). 330.e1–330.e8.
6.
Fuji, Shigeo, Ayumu Ito, Noriko Doki, et al.. (2024). Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation. Transplantation and Cellular Therapy. 30(5). 514.e1–514.e13.
7.
Takano, Kuniko, Keiji Ono, Miyuki Abe, et al.. (2023). Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study. Journal of Clinical and Experimental Hematopathology. 63(3). 197–200. 1 indexed citations
8.
Inoue, Yoshitaka, Keiji Okinaka, Shigeo Fuji, et al.. (2021). Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. Bone Marrow Transplantation. 56(9). 2125–2136. 5 indexed citations
10.
Kaito, Satoshi, Y. Nakajima, Konan Hara, et al.. (2020). Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation. Blood Advances. 4(6). 1051–1061. 19 indexed citations
11.
Ogata, Masao, Rie Kawano, Takako Satou, et al.. (2020). Kinetics and clinical significance of human herpesvirus 6 DNA shedding in saliva after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 23(3). e13512–e13512. 1 indexed citations
12.
Kato, Motohiro, Hideki Nakasone, Nobuaki Nakano, et al.. (2019). Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(6). 1023–1028. 2 indexed citations
13.
Nakasone, Hideki, Koji Kawamura, Kimikazu Yakushijin, et al.. (2019). BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient. Blood Advances. 3(11). 1750–1760. 5 indexed citations
14.
Takano, Kuniko, Masao Ogata, Takako Satou, et al.. (2019). Correlations of cytokine levels in cerebrospinal fluid and peripheral blood with outcome of HHV‐6B encephalitis after hematopoietic stem cell transplantation. Transplant Infectious Disease. 21(6). e13172–e13172. 4 indexed citations
15.
Ogata, Masao. (2015). [Human Herpesvirus-6 Encephalitis in Allogeneic Hematopoietic Stem Cell Transplantation].. PubMed. 67(7). 919–30. 2 indexed citations
17.
Kawasaki, Takashi, Masao Ogata, Chika Kawasaki, Kohji Okamoto, & Takeyoshi Sata. (2007). Effects of epidural anaesthesia on surgical stress-induced immunosuppression during upper abdominal surgery. British Journal of Anaesthesia. 98(2). 196–203. 56 indexed citations
18.
Amikura, Katsumi, Hirohiko Sakamoto, Daisuke Yoshinari, et al.. (2002). A Case of Early Carcinoma of the Papilla of Vater Diagnosed One Year after the Onset of Acute Pancreatitis.. The Japanese Journal of Gastroenterological Surgery. 35(12). 1798–1802. 1 indexed citations
19.
Ogata, Masao, Yuko Ogata, Kazuhiro Kohno, et al.. (1998). Eosinophilia associated with adult t-cell leukemia: Role of interleukin 5 and granulocyte-macrophage colony-stimulating factor. American Journal of Hematology. 59(3). 242–245. 24 indexed citations
20.
Ogata, Masao, et al.. (1990). [The effect of glucose loading on changes in ketone and glucose metabolism during gastrectomy].. PubMed. 39(4). 465–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026